What Steps Should Drug Companies Take In China To Be Ready For NMPA Audits?

Drug companies in China should ensure compliance with NMPA regulations, maintain accurate and up-to-date documentation, conduct regular internal audits, train staff on regulatory requirements, implement robust quality control systems, and stay informed about regulatory changes to be prepared for NMPA audits.

Leave a Reply

You must be logged in to post a comment.